Literature DB >> 19226196

Modification of endothelial nitric oxide synthase through AMPK after experimental subarachnoid hemorrhage.

Koji Osuka1, Yasuo Watanabe, Nobuteru Usuda, Kimie Atsuzawa, Jun Yoshida, Masakazu Takayasu.   

Abstract

Severe subarachnoid hemorrhage (SAH) induces dysfunction of endothelial nitric oxide synthase (eNOS), resulting in severe vasospasm. Clinically, however, some portions of cerebral arteries may show only mild vasospasm. Although severe vasospastic arteries after SAH have been intensively studied, activity of eNOS associated with the mild form of the disease has received less attention. The purpose of the present study was to clarify molecular mechanisms underlying the regulation of eNOS activity in mild vasospastic arteries after SAH. In a rat single-hemorrhage model, basilar arteries were obtained up to 7 days after SAH. Western blot analysis was used to study the temporal profiles of eNOS, phosphorylated (p)-eNOS at Ser(1177) or Thr(495), inducible NOS (iNOS), AMP-activated protein kinase alpha (AMPK alpha, p-AMPK alpha at Thr(172)Akt, p-Akt at Ser(473), cyclic AMP-dependent protein kinase (PKA), and p-PKA at Thr(197) in basilar arteries. Immunohistochemical studies were performed to examine the spatial expression patterns of p-eNOS at Ser(1177) and p-AMPK alpha at Thr(172). Western blot analysis showed eNOS to be significantly phosphorylated at Ser(1177) from 1 to 2 days after SAH, accompanied by upregulation of iNOS and AMPK, while activation states of Akt and PKA did not show significant change. Immunohistochemistry revealed phosphorylation of eNOS and AMPK alpha in endothelial cells of the basilar artery. SAH might thus induce temporary activation of AMPK alpha, which phosphorylates eNOS at Ser(1177) in endothelial cells of mild vasospastic basilar arteries. This signal transduction may play an important role in controlling cerebral blood flow after SAH.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19226196     DOI: 10.1089/neu.2008.0836

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  22 in total

Review 1.  AMPK inhibition in health and disease.

Authors:  Benoit Viollet; Sandrine Horman; Jocelyne Leclerc; Louise Lantier; Marc Foretz; Marc Billaud; Shailendra Giri; Fabrizio Andreelli
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-08       Impact factor: 8.250

2.  Chemerin plays a protective role by regulating human umbilical vein endothelial cell-induced nitric oxide signaling in preeclampsia.

Authors:  Liqiong Wang; Tianli Yang; Yiling Ding; Yan Zhong; Ling Yu; Mei Peng
Journal:  Endocrine       Date:  2014-05-20       Impact factor: 3.633

3.  Role of cyclic AMP sensor Epac1 in masseter muscle hypertrophy and myosin heavy chain transition induced by β2-adrenoceptor stimulation.

Authors:  Yoshiki Ohnuki; Daisuke Umeki; Yasumasa Mototani; Huiling Jin; Wenqian Cai; Kouichi Shiozawa; Kenji Suita; Yasutake Saeki; Takayuki Fujita; Yoshihiro Ishikawa; Satoshi Okumura
Journal:  J Physiol       Date:  2014-10-24       Impact factor: 5.182

4.  Vitamin D attenuates cerebral artery remodeling through VDR/AMPK/eNOS dimer phosphorylation pathway after subarachnoid hemorrhage in rats.

Authors:  Budbazar Enkhjargal; Jay Malaguit; Wing M Ho; Wu Jiang; Weifeng Wan; Gaiqing Wang; Jiping Tang; John H Zhang
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-21       Impact factor: 6.200

5.  Endothelial nitric oxide synthase mediates endogenous protection against subarachnoid hemorrhage-induced cerebral vasospasm.

Authors:  Ananth K Vellimana; Eric Milner; Tej D Azad; Michael D Harries; Meng-Liang Zhou; Jeffrey M Gidday; Byung Hee Han; Gregory J Zipfel
Journal:  Stroke       Date:  2011-02-11       Impact factor: 7.914

6.  Effects of metformin in experimental stroke.

Authors:  Jun Li; Sharon E Benashski; Venugopal Reddy Venna; Louise D McCullough
Journal:  Stroke       Date:  2010-09-16       Impact factor: 7.914

7.  Dissociation of hyperglycemia from altered vascular contraction and relaxation mechanisms in caveolin-1 null mice.

Authors:  Luminita H Pojoga; Tham M Yao; Lauren A Opsasnick; Amanda E Garza; Ossama M Reslan; Gail K Adler; Gordon H Williams; Raouf A Khalil
Journal:  J Pharmacol Exp Ther       Date:  2013-11-26       Impact factor: 4.030

Review 8.  Effects of AMP-activated protein kinase in cerebral ischemia.

Authors:  Jun Li; Louise D McCullough
Journal:  J Cereb Blood Flow Metab       Date:  2009-12-16       Impact factor: 6.200

9.  Liraglutide, a long-acting GLP-1 mimetic, and its metabolite attenuate inflammation after intracerebral hemorrhage.

Authors:  Jack Hou; Anatol Manaenko; Jakob Hakon; Jacob Hansen-Schwartz; Jiping Tang; John H Zhang
Journal:  J Cereb Blood Flow Metab       Date:  2012-09-12       Impact factor: 6.200

Review 10.  Function of the master energy regulator adenosine monophosphate-activated protein kinase in stroke.

Authors:  Bharti Manwani; Louise D McCullough
Journal:  J Neurosci Res       Date:  2013-03-06       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.